- Home
- TRMD vs TMDX Comparison
TRMD vs TMDX Comparison
Compare TRMD & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRMD
- TMDX
- Stock Information
- Founded
- TRMD 1889
- TMDX 1998
- Country
- TRMD United Kingdom
- TMDX United States
- Employees
- TRMD N/A
- TMDX N/A
- Industry
- TRMD Marine Transportation
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TRMD Consumer Discretionary
- TMDX Health Care
- Exchange
- TRMD Nasdaq
- TMDX Nasdaq
- Market Cap
- TRMD 1.9B
- TMDX 2.1B
- IPO Year
- TRMD N/A
- TMDX 2019
- Fundamental
- Price
- TRMD $20.39
- TMDX $57.20
- Analyst Decision
- TRMD Buy
- TMDX Buy
- Analyst Count
- TRMD 1
- TMDX 11
- Target Price
- TRMD $48.00
- TMDX $116.10
- AVG Volume (30 Days)
- TRMD 1.4M
- TMDX 2.6M
- Earning Date
- TRMD 03-06-2025
- TMDX 02-24-2025
- Dividend Yield
- TRMD 23.54%
- TMDX N/A
- EPS Growth
- TRMD N/A
- TMDX N/A
- EPS
- TRMD 7.70
- TMDX 0.94
- Revenue
- TRMD $1,641,593,000.00
- TMDX $401,090,000.00
- Revenue This Year
- TRMD N/A
- TMDX $81.61
- Revenue Next Year
- TRMD N/A
- TMDX $22.52
- P/E Ratio
- TRMD $2.77
- TMDX $61.04
- Revenue Growth
- TRMD 3.90
- TMDX 109.09
- 52 Week Low
- TRMD $17.77
- TMDX $56.03
- 52 Week High
- TRMD $40.47
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- TRMD 46.59
- TMDX 35.74
- Support Level
- TRMD $20.53
- TMDX $58.40
- Resistance Level
- TRMD $23.20
- TMDX $67.80
- Average True Range (ATR)
- TRMD 0.70
- TMDX 4.59
- MACD
- TRMD 0.24
- TMDX -0.27
- Stochastic Oscillator
- TRMD 35.25
- TMDX 4.44
About TRMD TORM plc
TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Exhaust segment.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.